SCHEMBL5964645

SCHEMBL5964645

CS(=O)(=O)Nc1ccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK1 P23458 10/20 0.74
▸ TYK2 P29597 10/20 0.74
▸ CDK1 P06493 10/20 0.74
▸ CDK2 P24941 8/20 0.74
▸ JAK3 P52333 7/20 0.74
▸ JAK2 O60674 6/20 0.74
▸ CCNB2 O95067 3/20 0.74
▸ CCNB1 P14635 3/20 0.74
▸ CCNB3 Q8WWL7 3/20 0.74
▸ PLK4 O00444 1/20 0.74
▸ STK25 O00506 1/20 0.74
▸ RIOK3 O14730 1/20 0.74
▸ AURKA O14965 1/20 0.74
▸ GAK O14976 1/20 0.74
▸ DCLK1 O15075 1/20 0.74
▸ PDPK1 O15530 1/20 0.74
▸ DAPK3 O43293 1/20 0.74
▸ NUAK1 O60285 1/20 0.74
▸ ROCK2 O75116 1/20 0.74
▸ RPS6KA4 O75676 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5964771 0.89 CDK1 (0.65) JAK1TYK2CDK1CDK2JAK3
Jnj-7706621 SCHEMBL1060773 0.85 CDK1 (1.00) JAK1TYK2CDK1CDK2JAK3
SCHEMBL5110157 0.85 CDK1 (0.83) JAK1TYK2CDK1CDK2JAK3
SCHEMBL7092328 0.85 CDK1 (0.78) JAK1TYK2CDK1CDK2JAK3
SCHEMBL14288380 0.85 JAK1 (1.00) JAK1TYK2CDK1CDK2JAK3
SCHEMBL5725874 0.84 CDK1 (0.77) JAK1TYK2CDK1CDK2JAK3
SCHEMBL7089472 0.82 CDK1 (0.78) JAK1TYK2CDK1CDK2JAK3
SCHEMBL14288391 0.80 JAK1 (0.73) JAK1TYK2CDK1CDK2JAK3
SCHEMBL14288368 0.79 CDK1 (1.00) JAK1TYK2CDK1CDK2JAK3
SCHEMBL7089505 0.79 CDK1 (0.69) JAK1TYK2CDK1CDK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1712550-A2 Substituted triazole diamine derivatives as kinase inhibitors Ortho-McNeil Pharmaceutical, Inc. (US) 2006-10-18 — — EP disclosed
Send feedback